Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patients

Conclusion High Ki67 expression is predictive of poor prognosis and of resistance to adjuvant tamoxifen therapy in postmenopausal BC. We recommend considering Ki67 as one of the risk factors that guide adjuvant treatment decisions.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research